Related Experiment Video

Updated: May 6, 2026

A Simplified Model for Heterotopic Heart Valve Transplantation in Rodents
06:33

A Simplified Model for Heterotopic Heart Valve Transplantation in Rodents

Published on: September 21, 2021

2.1K

Heart transplantation in pediatric cardiomyopathies

Brian F Birnbaum1, Kathleen E Simpson, Charles E Canter

  • 1Washington University in St. Louis and St. Louis Children's Hospital, 1 Children's Place Box 8116, St. Louis, MO 63110, USA.

Expert Review of Cardiovascular Therapy
|November 13, 2013
PubMed

Insights

Pediatric cardiomyopathies, including dilated, hypertrophic, restrictive, and left ventricular non-compaction, are serious heart conditions with genetic and non-genetic causes. Transplantation offers benefits but carries risks, with outcomes influenced by etiology and patient condition.

Area of Science:

  • Pediatric Cardiology
  • Genetics
  • Transplantation Medicine

Background:

  • Cardiomyopathies are uncommon but serious causes of heart disease in children.
  • Subtypes include dilated, hypertrophic, restrictive, and left ventricular non-compaction.
  • Both genetic and non-genetic factors contribute to pediatric cardiomyopathies.

Purpose of the Study:

  • To review the landscape of pediatric cardiomyopathies.
  • To discuss the role and outcomes of heart transplantation in pediatric patients.
  • To highlight the importance of mechanical circulatory support.

Main Methods:

  • Literature review of pediatric cardiomyopathies.
  • Analysis of factors influencing transplantation outcomes.
  • Discussion of current and emerging mechanical circulatory support technologies.

Main Results:

  • Pediatric cardiomyopathies have diverse etiologies and classifications.
  • Heart transplantation is a viable option but associated with significant risks.
  • Patient outcomes are closely tied to the underlying cause and pre-transplant condition.

Conclusions:

  • Understanding the specific etiology of pediatric cardiomyopathy is crucial for management.
  • Mechanical circulatory support plays a vital role in bridging patients to transplantation.
  • Continued development of supportive technologies is essential for improving outcomes.

More Related Videos

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft08:30

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft

Published on: February 14, 2022

2.6K
Transplantation of Pulmonary Valve Using a Mouse Model of Heterotopic Heart Transplantation10:56

Transplantation of Pulmonary Valve Using a Mouse Model of Heterotopic Heart Transplantation

Published on: July 23, 2014

17.9K

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
761
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
810
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
798